Serotonin  selective  reuptake  inhibitors  and  suicide  risk  in  a Portuguese adolescent sample

Duarte, Nuno; Amaral, Sarah; Abrantes, Marta

http://hdl.handle.net/10400.16/3818

Use this identifier to reference this record.

Name:	Description:	Size:	Format:
andreabuschbeck,+v32n03a04.pdf		638.41 KB	Adobe PDF	Download

Send Feedback

Authors

Duarte, Nuno

Amaral, Sarah

Abrantes, Marta

Abstract(s)

Background: The adolescent population is at high risk for depressive disorders, and suicide is a leading cause of death in this age group worldwide. Selective serotonin reuptake inhibitors (SSRIs) remain the only approved pharmacological approach, despite concerns about suicidality.Objectives: This study aimed to understand the relationship between antidepressant use and suicidality in an adolescent population from an Adolescent Psychiatric unit in Lisbon, Portugal. Methods: A total of 296 medical reports of adolescent patients with depressive symptoms in psychiatric follow-up at the considered unit were reviewed. Two demographically and clinically similar samples were obtained, one exposed to SSRI treatment and one control group. Results: A risk of suicide attempt of 0.006 was found in the group exposed to SSRIs versus 0.025 in the control group, corresponding to a relative risk of suicidality of 0.248. This difference did not reach statistical significance, despite a Bayes factor of 4.57 and a Pearson’s r of -0.078. Conclusions: The study results suggest that SSRIs do not increase the risk of suicide attempt in adolescents with depressive symptoms.